SHPMY:OTCMKTS
Shanghai Pharmaceuticals Holdings ADR
7,08 $
0,00%
(0,00) 1D
1 հոկ, 14:50:24 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SHPMY...
Mkt. cap
65,70 մլրդ
Avg. vol.
105,00
Volume
10,00
52-wk high
8,23 $
52-wk low
6,41 $
Beta
0,58
Shares outstanding
183,81 մլն
No. of employees
49 հզր
Mkt. cap
65,70 մլրդ
Avg. vol.
105,00
Volume
10,00
52-wk high
8,23 $
52-wk low
6,41 $
Beta
0,58
Shares outstanding
183,81 մլն
No. of employees
49 հզր
News stories
From web sources and news partners
Benzinga
·
1 ժամ առաջ
TruGolf Holdings (NASDAQ: TRUG) Taps Newly Acquired Polymath to Tokenize Franchise Ownership Records
The Olympian
·
39 րոպե առաջ
Nasdaq reports network disruption, US equities data feeds impacted
Profile
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
About Shanghai Pharmaceuticals Holdings ADR
CEO-
Employees48,6 հզր
Founded18 հնվ, 1994 թ.
Headquarters-
SectorHealth care provider
Websitesphchina.com